Stocklytics Platform
Asset logo for symbol ZTS
Zoetis
ZTS68
$179.84arrow_drop_down0.50%-$0.92
S&P500
Asset logo for symbol ZTS
ZTS68

$179.84

arrow_drop_down0.50%

AI Deep-Learning Forecast (ZTS)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Zoetis (ZTS) Stocklytics Forecast

Zoetis Inc (ZTS) is a leading global animal health company that specializes in the discovery, development, manufacture, and commercialization of veterinary vaccines, medicines, and diagnostics. With a strong focus on innovation and a deep understanding of the evolving needs of the animal health industry, Zoetis is well-positioned for future growth.
The stock price of Zoetis Inc (ZTS) has been on an upward trajectory in recent years, and many analysts believe this trend will continue. According to AI and machine learning predictions, ZTS stock is expected to maintain its positive momentum and experience steady growth. With a strong track record of delivering innovative products and a global presence, Zoetis is well-equipped to capitalize on the growing demand for animal health solutions.
add Zoetis  to watchlist

Keep an eye on Zoetis

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the analyst price prediction for Zoetis (ZTS) stock?
Analysts have set a target price of $217.48 for Zoetis (ZTS), based on forecasts from 23 analysts. The predicted price range extends from a high of $260 to a low of $180. This represents a potential increase of up to 44.57% and a decrease of 0.09% from the current price of $179.84. These forecasts are as of 2022 Jun 17.
help
What are the analyst ratings for Zoetis (ZTS) stock?
Currently, there are no analyst ratings available for Zoetis (ZTS), possibly due to insufficient coverage or recent updates.
help
What is the AI price prediction for Zoetis (ZTS) stock?
At present, there is no AI or machine-learning-based price prediction available for Zoetis (ZTS) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.
email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level